Viemed Healthcare, Inc. (VMD)
USD 6.67
(-3.13%)
USD 6.67
(-3.13%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 10.24 Million USD | 64.63% |
| 2022 | 6.22 Million USD | -31.82% |
| 2021 | 9.12 Million USD | -71.06% |
| 2020 | 31.53 Million USD | 269.85% |
| 2019 | 8.52 Million USD | -16.23% |
| 2018 | 10.17 Million USD | 24.47% |
| 2017 | 8.17 Million USD | 565.8% |
| 2016 | 1.22 Million USD | -86.24% |
| 2015 | 8.92 Million USD | -5.56% |
| 2014 | 9.45 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 1.46 Million USD | -8.42% |
| 2024 Q1 | 1.6 Million USD | -53.9% |
| 2023 Q2 | 2.33 Million USD | 53.59% |
| 2023 Q1 | 1.51 Million USD | -37.78% |
| 2023 Q4 | 3.47 Million USD | 19.12% |
| 2023 Q3 | 2.91 Million USD | 25.28% |
| 2023 FY | 10.24 Million USD | 64.63% |
| 2022 Q3 | 1.05 Million USD | 9.1% |
| 2022 Q4 | 2.43 Million USD | 131.09% |
| 2022 FY | 6.22 Million USD | -31.82% |
| 2022 Q1 | 1.76 Million USD | -56.89% |
| 2022 Q2 | 967 Thousand USD | -45.12% |
| 2021 Q4 | 4.08 Million USD | 128.45% |
| 2021 Q3 | 1.78 Million USD | 14.24% |
| 2021 Q2 | 1.56 Million USD | -7.01% |
| 2021 FY | 9.12 Million USD | -71.06% |
| 2021 Q1 | 1.68 Million USD | -66.79% |
| 2020 Q4 | 5.07 Million USD | 80.85% |
| 2020 FY | 31.53 Million USD | 269.85% |
| 2020 Q3 | 2.8 Million USD | -85.56% |
| 2020 Q2 | 19.41 Million USD | 357.51% |
| 2020 Q1 | 4.24 Million USD | 77.68% |
| 2019 Q1 | 2.15 Million USD | -29.28% |
| 2019 FY | 8.52 Million USD | -16.23% |
| 2019 Q4 | 2.38 Million USD | -19.32% |
| 2019 Q3 | 2.96 Million USD | 62.64% |
| 2019 Q2 | 1.82 Million USD | -15.51% |
| 2018 Q2 | 2.36 Million USD | 1.07% |
| 2018 Q3 | 2.42 Million USD | 2.45% |
| 2018 Q4 | 3.04 Million USD | 25.66% |
| 2018 FY | 10.17 Million USD | 24.47% |
| 2018 Q1 | 2.34 Million USD | 9103.85% |
| 2017 FY | 8.17 Million USD | 565.8% |
| 2017 Q2 | 1.77 Million USD | -26.46% |
| 2017 Q1 | 2.41 Million USD | -19.31% |
| 2017 Q3 | 4.01 Million USD | 126.62% |
| 2017 Q4 | -26 Thousand USD | -100.65% |
| 2016 Q4 | 2.98 Million USD | 670.1% |
| 2016 Q3 | 388 Thousand USD | 0.0% |
| 2016 FY | 1.22 Million USD | -86.24% |
| 2015 FY | 8.92 Million USD | -5.56% |
| 2014 FY | 9.45 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 116.623% |
| IceCure Medical Ltd | -14.65 Million USD | 169.909% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 186.37% |
| Acutus Medical, Inc. | -81.66 Million USD | 112.543% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | -1499.979% |
| Bioventus Inc. | -156.23 Million USD | 106.556% |
| BrainsWay Ltd. | -4.19 Million USD | 344.055% |
| Cerus Corporation | -37.48 Million USD | 127.323% |
| Venus Concept Inc. | -37.25 Million USD | 127.498% |
| Envoy Medical, Inc. | -29.9 Million USD | 134.248% |
| CVRx, Inc. | -41.19 Million USD | 124.862% |
| electroCore, Inc. | -18.83 Million USD | 154.386% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 215.74% |
| Inogen, Inc. | -102.44 Million USD | 109.998% |
| OrthoPediatrics Corp. | -20.97 Million USD | 148.837% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 119.449% |
| Spectral AI, Inc. | -20.85 Million USD | 149.118% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 174.52% |
| MaxCyte, Inc. | -37.92 Million USD | 127.01% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 116.854% |
| Nexalin Technology, Inc. | -4.64 Million USD | 320.341% |
| Orthofix Medical Inc. | -151.39 Million USD | 106.766% |
| PAVmed Inc | -64.17 Million USD | 115.961% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 119.523% |
| RxSight, Inc. | -48.6 Million USD | 121.073% |
| Sight Sciences, Inc. | -55.54 Million USD | 118.44% |
| SI-BONE, Inc. | -43.33 Million USD | 123.636% |
| TELA Bio, Inc. | -46.66 Million USD | 121.951% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 120.682% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 175.41% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 117.35% |
| LivaNova PLC | 17.54 Million USD | 41.622% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 193.498% |
| Talis Biomedical Corporation | -62 Million USD | 116.519% |
| 908 Devices Inc. | -36.39 Million USD | 128.141% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 105.488% |
| Nemaura Medical Inc. | -14.14 Million USD | 172.421% |
| NeuroPace, Inc. | -32.95 Million USD | 131.081% |
| LENSAR, Inc. | -14.38 Million USD | 171.216% |
| Apyx Medical Corporation | -18.71 Million USD | 154.737% |
| Cutera, Inc. | -162.83 Million USD | 106.29% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 194.58% |
| BioSig Technologies, Inc. | -29.04 Million USD | 135.271% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 112.391% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 146.371% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 84.879% |
| Axonics, Inc. | -6.08 Million USD | 268.249% |
| Outset Medical, Inc. | -172.79 Million USD | 105.928% |
| IRIDEX Corporation | -9.57 Million USD | 207.032% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 109.673% |
| IRadimed Corporation | 17.19 Million USD | 40.423% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 224.248% |
| INVO Bioscience, Inc. | -8.03 Million USD | 227.486% |
| Telesis Bio, Inc. | -47.72 Million USD | 121.463% |
| Varex Imaging Corporation | -47.7 Million USD | 121.474% |
| Quipt Home Medical Corp. | -2.78 Million USD | 467.924% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 190.758% |
| Pulmonx Corporation | -60.84 Million USD | 116.835% |
| Dynatronics Corporation | -2.69 Million USD | 479.691% |
| Modular Medical, Inc. | -17.47 Million USD | 158.632% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 189.953% |
| Semler Scientific, Inc. | 20.58 Million USD | 50.236% |
| InMode Ltd. | 197.91 Million USD | 94.825% |
| Bruker Corporation | 427.2 Million USD | 97.602% |
| Cytosorbents Corporation | -28.5 Million USD | 135.931% |
| DexCom, Inc. | 541.5 Million USD | 98.108% |
| Align Technology, Inc. | 445.05 Million USD | 97.698% |
| Viveve Medical, Inc. | -22.02 Million USD | 146.502% |
| ZimVie Inc. | -393.28 Million USD | 102.604% |
| Movano Inc. | -29.28 Million USD | 134.979% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 184.318% |
| Nexalin Technology, Inc. | -4.64 Million USD | 320.341% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | -1499.979% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 104.601% |
| Profound Medical Corp. | -28.56 Million USD | 135.854% |
| Insulet Corporation | 206.3 Million USD | 95.035% |
| enVVeno Medical Corporation | -23.51 Million USD | 143.558% |
| Surmodics, Inc. | -11.54 Million USD | 188.745% |
| iCAD, Inc. | -4.84 Million USD | 311.327% |
| Nuwellis, Inc. | -20.2 Million USD | 150.685% |
| Biotricity, Inc. | -14.09 Million USD | 172.675% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 108.3% |
| Aethlon Medical, Inc. | -12.2 Million USD | 183.903% |
| InspireMD, Inc. | -19.91 Million USD | 151.431% |
| PAVmed Inc. | -64.17 Million USD | 115.961% |
| BIOLASE, Inc. | -20.63 Million USD | 149.646% |
| Beyond Air, Inc. | -60.24 Million USD | 117.003% |
| FONAR Corporation | 10.56 Million USD | 3.07% |
| AxoGen, Inc. | -21.71 Million USD | 147.168% |
| Vivani Medical, Inc. | -25.65 Million USD | 139.931% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 64.079% |
| Inari Medical, Inc. | -1.63 Million USD | 726.1% |
| UFP Technologies, Inc. | 44.92 Million USD | 77.199% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | 299.578% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 255.075% |
| Tenon Medical, Inc. | -15.58 Million USD | 165.74% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 166.401% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 128.99% |
| AdaptHealth Corp. | -678.89 Million USD | 101.509% |
| Sintx Technologies, Inc. | -8.25 Million USD | 224.022% |
| NanoVibronix, Inc. | -3.71 Million USD | 376.017% |
| Quanterix Corporation | -32.33 Million USD | 131.679% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 190.758% |
| Sensus Healthcare, Inc. | 485 Thousand USD | -2011.959% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 103.339% |
| TransMedics Group, Inc. | -25.02 Million USD | 140.926% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 146.279% |
| NeuroMetrix, Inc. | -6.52 Million USD | 256.873% |
| Hyperfine, Inc. | -44.23 Million USD | 123.154% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 113.048% |
| Biomerica, Inc. | -5.97 Million USD | 271.345% |
| Bone Biologics Corporation | -8.94 Million USD | 214.463% |
| AVITA Medical, Inc. | -39.16 Million USD | 126.151% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 202.905% |
| Silk Road Medical, Inc | -55.74 Million USD | 118.375% |